1. Home
  2. KURA vs ARRY Comparison

KURA vs ARRY Comparison

Compare KURA & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • ARRY
  • Stock Information
  • Founded
  • KURA 2014
  • ARRY 1989
  • Country
  • KURA United States
  • ARRY United States
  • Employees
  • KURA N/A
  • ARRY N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • ARRY Semiconductors
  • Sector
  • KURA Health Care
  • ARRY Technology
  • Exchange
  • KURA Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • KURA 561.9M
  • ARRY 785.6M
  • IPO Year
  • KURA N/A
  • ARRY 2020
  • Fundamental
  • Price
  • KURA $6.44
  • ARRY $7.47
  • Analyst Decision
  • KURA Strong Buy
  • ARRY Buy
  • Analyst Count
  • KURA 12
  • ARRY 20
  • Target Price
  • KURA $24.50
  • ARRY $9.47
  • AVG Volume (30 Days)
  • KURA 1.4M
  • ARRY 10.9M
  • Earning Date
  • KURA 08-07-2025
  • ARRY 08-07-2025
  • Dividend Yield
  • KURA N/A
  • ARRY N/A
  • EPS Growth
  • KURA N/A
  • ARRY N/A
  • EPS
  • KURA N/A
  • ARRY N/A
  • Revenue
  • KURA $67,991,000.00
  • ARRY $1,064,767,000.00
  • Revenue This Year
  • KURA $125.04
  • ARRY $24.15
  • Revenue Next Year
  • KURA $83.75
  • ARRY $13.19
  • P/E Ratio
  • KURA N/A
  • ARRY N/A
  • Revenue Growth
  • KURA N/A
  • ARRY N/A
  • 52 Week Low
  • KURA $5.41
  • ARRY $3.76
  • 52 Week High
  • KURA $23.48
  • ARRY $12.06
  • Technical
  • Relative Strength Index (RSI)
  • KURA 59.02
  • ARRY 54.13
  • Support Level
  • KURA $5.65
  • ARRY $7.22
  • Resistance Level
  • KURA $6.46
  • ARRY $7.92
  • Average True Range (ATR)
  • KURA 0.26
  • ARRY 0.50
  • MACD
  • KURA 0.07
  • ARRY 0.06
  • Stochastic Oscillator
  • KURA 97.73
  • ARRY 77.49

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: